Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors

Haemophilia

Volumn 12, Issue 2, 2006, Pages 154-162

  Scalone, L ^a   Mantovani, Lorenzo G ^a,b   Mannucci, P M ^a   Gringeri, A ^a   Baudo, F ^c   Berrettini, M ^d   Bertolino, G ^e   Bizzoni, L ^f   Longo, G ^g   Musso, R ^h   Santagostino, E ⁱ   Rocino, A ^j   Scaraggi, A F ^k   Tagariello, G ^l   Tagliaferri, A ^m  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d Ospedale Civile   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

^h GARIBALDI HOSPITAL   (Italy)

ⁱ FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^j Ospedale S Giovanni Bosco   (Italy)

^k Ospedale Consorziale Policlinico   (Italy)

^l Ospedale Civile   (Italy)

^m Ospedale Policlinico   (Italy)

more..

Author keywords

Haemophilia; Haemophilic arthropathy; Inhibitors; Orthopaedic joint score; Quality of life

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR;

ADULT; AGE; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FREQUENCY ANALYSIS; HEMARTHROSIS; HEMOPHILIA; HUMAN; ITALY; MUSCULOSKELETAL DISEASE; ORTHOPEDICS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; WELLBEING;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD COAGULATION FACTOR INHIBITORS; EPIDEMIOLOGIC METHODS; FACTOR IX; FACTOR VII; HEALTH STATUS INDICATORS; HEMOPHILIA A; HEMOPHILIA B; HUMANS; ISOANTIBODIES; JOINT DISEASES; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 33645963126     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01204.x     Document Type: Article

References (35)

1. Hall M. Haemophilia complicated by an acquired circulating anticoagulant: A report of three cases. Br J Haematol 1961; 7: 340-8.
2. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: A systematic review. Haemophilia 2003; 9: 418-35.
3. Di Michele DM. Inhibitors in haemophilia: A primer. Haemophilia 2000; 6 (Suppl. 1): 38-40.
4. Rosendaal FR, Varekamp I, Smit C et al. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989; 71: 71-76.
5. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with haemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102: 2358-63.
6. Chang H, Sher GD, Blanchette VS, Teitel JM. The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in Canada. Haemophilia 1999; 5: 247-52.
7. Goudemand J. Treatment of patients with inhibitors: Cost issues. Haemophilia 1999; 5: 397-401.
8. Royal S, Schramm W, Berntorp E et al. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002; 8: 44-50.
9. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
10. Gilbert MS. Prophylaxis: Musculoskeletal evaluation. Semin Hematol 1993; 30 (Suppl. 2): 3-6.
11. Brooks R. Euroqol: The current state of play. Health Policy 1996; 37: 53-72.
12. The EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
13. Apolone G, Mosconi P. The Italian SF-36 halth survey: Translation, validation and norming. J Clin Epidemiol 1998; 51: 1025-36.
14. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I.Conceptual framework and item selection. Med Care 1992; 30: 473-83.
15. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001; 7: 53-63.
16. Aznar JA, Magallón M, Querol F, Gorina E, Tusell JM. The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 2000; 6: 170-6.
17. Molho P, Rolland N, Lebrun T et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. Haemophilia 2000; 6: 23-32.
18. Salaffi F, Carotti M, Grassi W. Health-related quality of life in patients with hip or knee osteoarthritis. Comparison of generic and disease-specific instruments. Clin Rheumatol 2005; 24: 29-37.
19. Wolfe F, Kong SX, Watson DJ. Gastrointestinal symptoms and health related quality of life in patients with arthritis. J Rheumatol 2000; 27: 1373-8.
20. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-9.
21. Talamo J, Frater A, Gallivan S, Young A. Use of the Short Form 36 (SF-36) for health status measurement in rheumatoid arthritis. Br J Rheumatol 1997; 36: 463-9.
22. Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol 1997; 36: 884-8.
23. Wolfe F, Hawley DJ. Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 1997; 36: 786-93.
24. Hawker G, Melfi C, Paul J, Green R, Bombardier C. Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol 1995; 22: 1193-6.
25. Ware J Jr, Gandek B, Kosinski M et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1167-70.
26. Ware J Jr, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, Massachussetts: The Health Institute, 1994.
27. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
28. Barr RD, Saleh M, Furlong W et al. Health status and health-related quality of life associated with haemophilia. Am J Hematol 2002; 71: 152-60.
29. Wang T, Zhang L, Li H, Zhao H, Yang R. Assessing health-related quality-of-life in individuals with haemophilia in China. Haemophilia 2004; 10: 370-5.
30. Shapiro A, Donfield SM, Lynn HS et al. Defining the impact of haemophilia: The academic achievement in children with haemophilia study. Pediatrics 2001; 108: E105.
31. Liesner RJ, Khair K, Hann IM. The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol 1996; 92: 973-8.
32. Naraine VS, Risebrough NA, Oh P et al. Health-related quality-of-life treatments for severe haemophilia: Utility measurements using the Standard Gamble technique. Haemophilia 2002; 8: 112-20.
33. Djulbegovic B, Goldsmith G, Vaughn D et al. Comparison of quality of life between HIV-positive haemophilia patients and HIV-negative haemophilia patients. Haemophilia 1996; 2: 166-72.
34. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ 1998; 316: 736-41.
35. Apolone G, Mosconi P, Ware JE Jr. Questionario sullo Stato di Salute SF-36. Manuale d'uso e guida all'interpretazione dei risultati. Milano, Italy: Guerini e Associati, 1997.